These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33709269)
21. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children. Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629 [TBL] [Abstract][Full Text] [Related]
22. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? Lai SW; Goldman MP J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524 [TBL] [Abstract][Full Text] [Related]
23. Effects of sulodexide on stability of sclerosing foams. Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533 [TBL] [Abstract][Full Text] [Related]
24. An investigation on the influence of glycerin on sclerosant foam stability. Peterson JD; Goldman MP Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429 [TBL] [Abstract][Full Text] [Related]
25. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834 [TBL] [Abstract][Full Text] [Related]
26. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate. Wong K; Connor DE; Andrade OC; Parsi K Phlebology; 2021 Aug; 36(7):576-587. PubMed ID: 33736561 [TBL] [Abstract][Full Text] [Related]
27. A 6-year experience treating vascular malformations with foam sclerotherapy. Markovic JN; Kim CY; Lidsky ME; Shortell CK Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935 [TBL] [Abstract][Full Text] [Related]
28. Not all venous malformations needed therapy because they are not arteriovenous malformations. Lee BB Dermatol Surg; 2010 Mar; 36(3):347. PubMed ID: 20100266 [No Abstract] [Full Text] [Related]
29. Conjunctival Retention Cysts: Outcomes of Aspiration and Sclerotherapy With Sodium Tetradecyl Sulfate. Dave T; Taneja S; Tiple S; Basu S; Naik MN Ophthalmic Plast Reconstr Surg; 2019; 35(2):165-169. PubMed ID: 30148745 [TBL] [Abstract][Full Text] [Related]
30. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413 [TBL] [Abstract][Full Text] [Related]
31. Use of percutaneous foam sclerotherapy with 1.5% sodium tetradecyl sulfate for treatment of a pelvic limb venous malformation in a dog. Chang S; Weisse C; Berent AC; Rosen RJ J Am Vet Med Assoc; 2020 Jun; 256(12):1368-1374. PubMed ID: 32459582 [TBL] [Abstract][Full Text] [Related]
32. An institution-wide algorithm for direct-stick embolization of peripheral venous malformations. Nassiri N; Huntress LA; Simon M; Murphy S J Vasc Surg Venous Lymphat Disord; 2018 May; 6(3):351-357. PubMed ID: 29396158 [TBL] [Abstract][Full Text] [Related]
37. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. Peterson JD; Goldman MP Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097 [TBL] [Abstract][Full Text] [Related]